Epidemiology of vancomycin usage at a children's hospital, 1993 through 1995

R L Sinkowitz1, H Keyserling, T J Walker

  • 1Hospital Infections Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.

Insights

Vancomycin use decreased in children

Area of Science:

  • Pediatric Infectious Diseases
  • Antimicrobial Stewardship
  • Health Informatics

Background:

  • Vancomycin is a critical antibiotic for treating serious Gram-positive bacterial infections.
  • Understanding patterns of vancomycin usage in pediatric populations is essential for effective antimicrobial stewardship.
  • Pharmacy databases offer a valuable resource for analyzing drug utilization trends.

Purpose of the Study:

  • To characterize the epidemiology of vancomycin utilization within a children's hospital setting.
  • To identify patient demographics, service lines, and trends associated with vancomycin use.
  • To provide data for targeted interventions aimed at optimizing antibiotic prescribing.

Main Methods:

  • A retrospective cohort study was conducted at Egleston Children's Hospital.
  • Data on vancomycin charges were extracted from pharmacy records within the hospital's information system.
  • The study period spanned from October 1992 to October 1995, encompassing 3589 patient hospitalizations.

Main Results:

  • Vancomycin was administered in 3589 hospitalizations, with a median of 11 doses per patient.
  • The majority of vancomycin doses (75.7%) were prescribed by hematology, neurosurgery, cardiothoracic surgery, neonatology, and general pediatrics services.
  • Despite a significant decrease in vancomycin doses over the study period (P < 0.001), usage remained substantial, particularly in surgery services.

Conclusions:

  • Pharmacy charge data are effective for monitoring antimicrobial use.
  • While vancomycin use declined, significant prescribing persisted, especially among subspecialty services.
  • Future interventions to reduce vancomycin use should prioritize hematology, neurosurgery, cardiothoracic surgery, neonatology, and general pediatrics.
Abstract

Related Concept Videos

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...